James F.

James F. is a highly experienced professional in the pharmaceutical and biotech industry. James currently serves as the Chairman & Chief Executive Officer at TNA Therapeutics. Previously, James held leadership roles at companies such as Tripp & Associates, GLG, Ascentage Pharma, Glenmark Pharmaceuticals, Tiziana Life Sciences, RASNA THERAPEUTICS LIMITED, Novo Nordisk, Regeneron Pharmaceuticals, and Merck. James F. has a solid educational background with graduate studies in Health and Policy Management from Harvard T.H. Chan School of Public Health, Molecular Biology from Harvard University, and a Bachelor of Science in Psychology/Biology (Dual major) with a minor in Business from Iona University.